corporate_fare
Sundance Biosciences Inc.
- Address
- 343 Oyster Point Boulevard Ste 120
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
1
research centre
public
1
country
person_search
1
investigator
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 2a Study of Oral SUN-627 for Safety, Tolerability, PK/PD, and CNS Neuroinflammation in Non‑Active Progressive Multiple Sclerosis (SPMS/PPMS) |  Finland | Not Yet Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centrelocation_city
assignment206Turku University Hospital
- Address
- Kiinamyllynkatu 4-8, 20520 Turku
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Sundance Biosciences Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.